These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11101850)

  • 1. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia).
    Nicole S; Davoine CS; Topaloglu H; Cattolico L; Barral D; Beighton P; Hamida CB; Hammouda H; Cruaud C; White PS; Samson D; Urtizberea JA; Lehmann-Horn F; Weissenbach J; Hentati F; Fontaine B
    Nat Genet; 2000 Dec; 26(4):480-3. PubMed ID: 11101850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of HSPG2 (Perlecan) mutations in patients with Schwartz-Jampel syndrome.
    Stum M; Davoine CS; Vicart S; Guillot-Noël L; Topaloglu H; Carod-Artal FJ; Kayserili H; Hentati F; Merlini L; Urtizberea JA; Hammouda el-H; Quan PC; Fontaine B; Nicole S
    Hum Mutat; 2006 Nov; 27(11):1082-91. PubMed ID: 16927315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome.
    Rodgers KD; Sasaki T; Aszodi A; Jacenko O
    Hum Mol Genet; 2007 Mar; 16(5):515-28. PubMed ID: 17213231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia.
    Arikawa-Hirasawa E; Le AH; Nishino I; Nonaka I; Ho NC; Francomano CA; Govindraj P; Hassell JR; Devaney JM; Spranger J; Stevenson RE; Iannaccone S; Dalakas MC; Yamada Y
    Am J Hum Genet; 2002 May; 70(5):1368-75. PubMed ID: 11941538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.
    Stum M; Girard E; Bangratz M; Bernard V; Herbin M; Vignaud A; Ferry A; Davoine CS; Echaniz-Laguna A; René F; Marcel C; Molgó J; Fontaine B; Krejci E; Nicole S
    Hum Mol Genet; 2008 Oct; 17(20):3166-79. PubMed ID: 18647752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.
    Echaniz-Laguna A; Rene F; Marcel C; Bangratz M; Fontaine B; Loeffler JP; Nicole S
    Muscle Nerve; 2009 Jul; 40(1):55-61. PubMed ID: 19367640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
    Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
    Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel HSPG2 mutations causing Schwartz‑Jampel syndrome type 1 in a Chinese family: A case report.
    Yan W; Dai J; Shi D; Xu X; Han X; Xu Z; Chen D; Teng H; Jiang Q
    Mol Med Rep; 2018 Aug; 18(2):1761-1765. PubMed ID: 29901129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwartz-Jampel syndrome and perlecan deficiency.
    Stum M; Davoine CS; Fontaine B; Nicole S
    Acta Myol; 2005 Oct; 24(2):89-92. PubMed ID: 16550923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report.
    Ho NC; Sandusky S; Madike V; Francomano CA; Dalakas MC
    BMC Neurol; 2003 Jul; 3():3. PubMed ID: 12839625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schwartz-Jampel syndrome(chondrodystrophic myotonia)].
    Arikawa-Hirasawa E
    Ryoikibetsu Shokogun Shirizu; 2001; (35):126-9. PubMed ID: 11555888
    [No Abstract]   [Full Text] [Related]  

  • 12. A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space.
    Iwata S; Ito M; Nakata T; Noguchi Y; Okuno T; Ohkawara B; Masuda A; Goto T; Adachi M; Osaka H; Nonaka R; Arikawa-Hirasawa E; Ohno K
    Neuromuscul Disord; 2015 Aug; 25(8):667-71. PubMed ID: 26031903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping.
    Nicole S; Ben Hamida C; Beighton P; Bakouri S; Belal S; Romero N; Viljoen D; Ponsot G; Sammoud A; Weissenbach J
    Hum Mol Genet; 1995 Sep; 4(9):1633-6. PubMed ID: 8541852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity in Schwartz-Jampel syndrome: two families with neonatal Schwartz-Jampel syndrome do not map to human chromosome 1p34-p36.1.
    Brown KA; al-Gazali LI; Moynihan LM; Lench NJ; Markham AF; Mueller RF
    J Med Genet; 1997 Aug; 34(8):685-7. PubMed ID: 9279765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel splice site HSPG2 mutation and prenatal diagnosis in Schwartz Jampel Syndrome type 1 using whole exome sequencing.
    Das Bhowmik A; Dalal A; Matta D; Kandadai RM; Kanikannan MA; Aggarwal S
    Neuromuscul Disord; 2016 Nov; 26(11):809-814. PubMed ID: 27521129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive Schwartz-Jampel syndrome (SJS): confirmation of linkage to chromosome 1p, evidence of genetic homogeneity and reduction of the SJS locus to a 3-cM interval.
    Fontaine B; Nicole S; Topaloglu H; Ben Hamida C; Beighton P; Spaans F; Cantu JM; Bakouri S; Romero N; Ricker K; Barros-Nunez P; Ponsot G; Ben Hamida M; Weissenbach J; Hentati F; Lehmann-Horn F
    Hum Genet; 1996 Sep; 98(3):380-5. PubMed ID: 8707312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the heparan sulfate proteoglycan perlecan on human disease and health.
    Arikawa-Hirasawa E
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1117-C1122. PubMed ID: 35417267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of Schwartz-Jampel syndrome with cleft palate.
    Abdel-Aziz M; Azab NA
    Int J Pediatr Otorhinolaryngol; 2009 Nov; 73(11):1601-3. PubMed ID: 19733405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia.
    Boerkoel CF; Takashima H; John J; Yan J; Stankiewicz P; Rosenbarker L; André JL; Bogdanovic R; Burguet A; Cockfield S; Cordeiro I; Fründ S; Illies F; Joseph M; Kaitila I; Lama G; Loirat C; McLeod DR; Milford DV; Petty EM; Rodrigo F; Saraiva JM; Schmidt B; Smith GC; Spranger J; Stein A; Thiele H; Tizard J; Weksberg R; Lupski JR; Stockton DW
    Nat Genet; 2002 Feb; 30(2):215-20. PubMed ID: 11799392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation.
    Gürbüz G; Albayrak HM
    Turk J Pediatr; 2019; 61(6):967-970. PubMed ID: 32134596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.